Jianxin Ge
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tegoprazan-based dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective, multicenter, open-label, non-inferiority, randomized controlled trial.
Journal: Scientific reports
Published: April 09, 2026
A reaction-based fluorescence for monitoring β-Gal in living cells and BALB/c nude mice.
Journal: Scientific reports
Published: February 27, 2026
Combined endovascular and surgical management of acute superior mesenteric artery embolism complicated by intestinal necrosis: a case report.
Journal: Frontiers in medicine
Published: January 27, 2026
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial.
Journal: Helicobacter
Published: February 24, 2025
Pan-cancer and multi-omics analysis: NDUFA1 is a potential therapeutic target and prognostic marker for esophageal cancer.
Journal: Cell biology and toxicology
Published: August 09, 2024
The clinical advantages of endoscopic submucosal dissection compared with endoscopic mucosal resection for early oesophageal cancer and pre-cancer lesions.
Journal: Journal of minimal access surgery
Published: March 21, 2024
Expression of biogenesis of ribosomes BRX1 is associated with malignant progression and prognosis in colorectal cancer.
Journal: Translational cancer research
Published: July 03, 2020
miR-548c-5p inhibits colorectal cancer cell proliferation by targeting PGK1.
Journal: Journal of cellular physiology
Published: December 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026